September 14, 2015 — University of Arkansas for Medical Sciences (UAMS) researcher Vladimir Zharov, Ph.D., D.Sc., was ...
The use of radiation therapy to treat cancer has been in existence for over a century, tracing back to the early days of ...
Navigating coverage decisions can be overwhelming and confusing, especially for high-end imaging equipment, where ...
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
The buzz term “big data” has made a rapid entry onto the healthcare scene in the past couple years with promises of ...
Value-driven health platform Spreemo has completed the first phase of a study to determine how interpretative variability in magnetic resonance imaging (MRI), a standard diagnostic test, can influence the course of a patient’s treatment.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals, announced the arrival of a 70 MeV Cyclotron at its new production facility in Noblesville, Indiana.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Westinghouse Electric Company and NorthStar Medical Radioisotopes announced a memorandum of understanding to explore producing medical radioisotopes from the core of commercial nuclear reactors, and methods of global distribution. The exploration involves generating the most widely used radioisotope in medical diagnostic imaging by treating an isotope of the chemical element molybdenum rather than enriched uranium.
Delphinus Medical Technologies Inc. announced that it has secured a venture round of $39.5 million, the single largest amount ever raised for a healthcare imaging company in the Midwest. It is also the largest amount for a medical device company in Michigan.
Tiny gas microbubbles can enhance the delivery and absorption of cancer drugs in patients with advanced pancreatic cancer, according to a new pilot study. The study was described at the International Contrast Ultrasound Society (ICUS) annual conference in Chicago.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Women who have breast cancer on their left side present a particular challenge to radiation oncologists. Studies have ...
The transition from film to flat panel has dramatically improved the efficiency of portable X-ray units. Transmitting ...
September 9, 2015 — The U.S. Food and Drug Administration (FDA) granted 510(k) for Philips Healthcare’s Spectral ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Ninety-six percent of clinics and hospitals in the United States that have purchased used or refurbished medical equipment have had neutral-to-positive experiences with the purchase, according to a new survey.
More than 50 women in need received free cervical and breast cancer screenings with same-day results as part of a recent See, Test & Treat program and health fair at Loyola University Medical Center.
SRI International and DataSpeaks Inc. announced that SRI has licensed the Science of Individuality Measurement Algorithm (SIMA) software from DataSpeaks. SRI will integrate SIMA into the development of a secure enterprise system for clinical decision-making.
Varian Medical Systems is collaborating with two leading Cape Town universities to launch Africa's first 'Access to Care' program, designed to train cancer caregivers in delivering advanced conformal radiotherapy treatments.
When 64-slice computed tomography (CT) systems were introduced nearly a decade ago, they were purchased in large numbers ...
In many ways, medical imaging is the backbone of the entire healthcare industry. Medical professionals can only treat ...
Brainlab announced that its Automatic Brain Metastases Planning software has been used for the first time in the United States at Jefferson Hospital for Neuroscience in Philadelphia.